PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Medical device pioneer Stentys, which has designed a new-generation stent platform for treatment of (1) acute myocardial infarction (AMI) and (2) coronary artery bifurcations, announced today that it has appointed interventional cardiology veteran Paul Geudens as Vice President of Sales & Marketing, effective immediately.
